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Targeting miR-223 in neutrophils enhances
the clearance of Staphylococcus aureus in
infected wounds
Maiko de Kerckhove1, Katsuya Tanaka1,2,3, Takahiro Umehara4, Momoko Okamoto1,5,
Sotaro Kanematsu6, Hiroko Hayashi1, Hiroki Yano2, Soushi Nishiura1, Shiho Tooyama1,
Yutaka Matsubayashi7,8, Toshimitsu Komatsu1, Seongjoon Park1, Yuka Okada9, Rina Takahashi10,
Yayoi Kawano10, Takehisa Hanawa10, Keisuke Iwasaki11, Tadashige Nozaki12, Hidetaka Torigoe13,
Kazuya Ikematsu4, Yutaka Suzuki6, Katsumi Tanaka2, Paul Martin7 , Isao Shimokawa1 &
Ryoichi Mori1,*
Abstract
Argonaute 2 bound mature microRNA (Ago2-miRNA) complexes are
key regulators of the wound inflammatory response and function
in the translational processing of target mRNAs. In this study, we
identified four wound inflammation-related Ago2-miRNAs (miR-
139-5p, miR-142-3p, miR-142-5p, and miR-223) and show that miR-
223 is critical for infection control. miR-223Y/ mice exhibited
delayed sterile healing with prolonged neutrophil activation and
interleukin-6 expression, and markedly improved repair of Staphy-
lococcus aureus-infected wounds. We also showed that the expres-
sion of miR-223 was regulated by CCAAT/enhancer binding protein
alpha in human neutrophils after exposure to S. aureus peptides.
Treatment with miR-223Y/-derived neutrophils, or miR-223
antisense oligodeoxynucleotides in S. aureus-infected wild-type
wounds markedly improved the healing of these otherwise chronic,
slow healing wounds. This study reveals how miR-223 regulates
the bactericidal capacity of neutrophils at wound sites and indi-
cates that targeting miR-223 might be of therapeutic benefit for
infected wounds in the clinic.
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Introduction
After tissue damage to the adult skin, there always follows a robust
recruitment of inflammatory cells, including innate immune cells,
neutrophils, and macrophages, into the wounded tissues to kill and
phagocytose invading microbes as well as secreting bioactive
substances that aid tissue repair (Eming et al, 2017). Healing of the
damaged tissue is accomplished by the concerted actions of re-
epithelialization and wound angiogenesis and by migration and
subsequent contraction of fibroblasts that lay down granulation
tissue by deposition of collagen and other matrix components
(Eming et al, 2014). These contributing cell behaviors are thought
to be partly governed by signals from the inflammatory cell influx
(Eming et al, 2007). Following collagen deposition, a scar develops
at the healed wound site (Eming et al, 2014). Interestingly, skin
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wounds of embryos and late gestation fetuses (before embryonic
day 15 in mice and end of second trimester in humans) can result in
almost perfect repair without scarring and these early wounds are
associated with a markedly reduced wound inflammatory response
(Hopkinson-Woolley et al, 1994), suggesting that inflammation
might cause skin fibrosis (Martin & Leibovich, 2005). Indeed,
neonatal PU.1-deficient (PU.1/) mice, which possess no neutro-
phils, macrophages, mast cells, or T cells, exhibit rapid repair and
scarless healing in contrast to wild-type (WT) siblings (Martin et al,
2003; Cooper et al, 2005). We previously showed that knockdown
of osteopontin, a wound upregulated inflammation-dependent gene,
by antisense oligodeoxynucleotides (AS ODNs) at wound sites
reduced scarring and improved healing in vivo (Mori et al, 2008). A
similar effect was observed for wounds by knockdown of the tran-
scription factor Foxo1 (Mori et al, 2014). In general, these findings
suggest that gene therapies based on dampening wound inflamma-
tory responses (reducing inflammatory cell influx, blocking pro-
fibrotic signals from inflammatory cells once they arrive at the
wound site, or enhancing the resolution of inflammation; Cash et al,
2014) might provide novel molecular therapeutic targets.
MicroRNAs (miRNAs) of the small, non-coding RNA family are
approximately 20–25 nucleotides of single-stranded RNA that regu-
late translational processing of target mRNAs (Winter et al, 2009).
miRNAs are degraded by selective loading into an RNA-induced
silencing complex (RISC) with Argonaute (Ago) as its core. Ago
family members (Ago1-4) are ubiquitously expressed, but Ago2 is
the most highly expressed and exhibits miRNA silencer activity in
mice (Liu et al, 2004). Many studies have now indicated that a
number of diverse miRNAs are involved with, and regulate,
inflammatory responses in humans and mice (O’Connell et al,
2012). Furthermore, the specific miRNAs miR-21 (Wang et al, 2012),
miR-130a (Pastar et al, 2012), and miR-132 (Li et al, 2015)
contribute to the healing of skin wounds. miRNA profiling using
next-generation sequencing (NGS) has already proved successful in
identifying novel miRNAs from several tissues and organisms (Tam
et al, 2014; Ma et al, 2015). However, methods to purify Ago2-
miRNA complexes from wound sites and miRNA library construction
to perform NGS from these tissues have not previously been reported.
miR-223Y/ mice have an expanded granulocytic compartment
resulting from a cell-autonomous increase in the number of granulo-
cyte progenitors (Johnnidis et al, 2008). Moreover, miR-223 is over-
expressed in rheumatoid arthritis patients (Fulci et al, 2010).
Together, these studies suggest that inflammation-related miRNAs,
particularly miR-223, might be key regulators of the inflammatory
response and/or its subsequent resolution during skin tissue repair;
however, the pathways involved have not been comprehensively
characterized.
In this study, we developed a unique purification system to
isolate functional miRNA-Ago2 complexes from wounded skin
tissues by immunoprecipitation (IP) using an anti-Ago2 antibody
(Ab), followed by the construction of libraries to perform NGS and
identify candidate wound inflammation-related miRNAs. Using this
approach, we identified several inflammation-dependent miRNAs
including miR-139-5p, miR-142-3p, miR-142-5p, and miR-223. Of
these, miR-223 was the most highly expressed in wound sites during
the inflammatory phase and so the present study focused on the
molecular mechanisms of miR-223 in skin wound healing. Our
wound healing studies showed the delayed repair of aseptic wounds
in miR-223Y/ mice was associated with enhanced neutrophil activa-
tion and interleukin-6 (Il6) expression. However, if wounds were
infected with Staphylococcus aureus, then miR-223Y/ mice showed
considerably enhanced repair compared with WT infected wounds,
and either transplanting miR-223Y/ neutrophils or the delivery of
miR-223 AS ODNs to infected WT wounds rescued the impaired
wound healing phenotype. The expression level of
miR-223 in human neutrophils was regulated by CCAAT/enhancer
binding protein alpha (C/EBPa) after exposure to S. aureus
peptides. Thus, miR-223 is a potential therapeutic target for the
treatment of skin wounds infected with S. aureus.
Results
Over 300 Ago2-miRNAs are expressed during skin wound healing
To comprehensively identify wound-induced mature miRNAs
involved in skin wound healing, a 4-mm-diameter wound was made
in WT mouse dorsal skin, and 6-mm-diameter unwounded and
wound sites were harvested on day 1, 3, 7, 10, and 14 after injury as
described previously (Mori et al, 2008, 2014). Because mature Ago2-
miRNA complexes bind to target mRNAs and inhibit their transla-
tion, we isolated Ago2-miRNA complexes rather than total miRNAs.
We purified Ago2-miRNA complexes from skin wound tissues by IP
with Ago2 Ab, followed by library generation and NGS with the Illu-
mina platform (Appendix Fig S1). Known murine miRNA sequencing
reads accounted for 76.6–91.0% of all sequence reads in our small
RNA libraries that were highly enriched for mature miRNA
sequences (Appendix Table S1). We identified over 300 known
murine miRNA categories expressed during skin wound healing
(Dataset EV1), demonstrating the high efficiency of our NGS proce-
dure for identifying functional miRNAs from skin wound tissues.
miR-139-5p, miR-142 family members, and miR-223 are wound
inflammation-related miRNAs
As a partial filter to identify inflammation-related miRNAs in skin
wound healing, miRNAs in the inflammatory phase (day 1 after
injury) were arranged by rank of upregulation and compared with
intact skin (Appendix Table S2). miRNA expression levels were
confirmed by qPCR (Fig 1). miR-147, miR-223 (miR-223-3p), miR-
129-3p, miR-129-5p, miR-139-5p, miR-21* (miR-21-3p), miR-340-5p,
miR-142-3p, and miR-142-5p expressions at wound sites on day 1
after injury were significantly increased compared with intact skin.
In WT neonatal mice, miR-223 and miR-142-3p expression levels
were markedly increased, peaking at 12 h after injury compared
with intact skin, and were subsequently significantly decreased by
24 h (Fig 2A) indicating a temporal association with the inflamma-
tory phase of healing. To confirm that these were inflammation-
related miRNAs expressed during skin wound healing, we made a
1-cm incisional wound in the dorsal skin of WT neonatal mice and
compared miR expression with heterozygous PU.1-deficient
(PU.1+/) and PU.1/ mice. qPCR analysis showed miR-223, miR-
142-3p, miR-142-5p, and miR-139-5p expression levels at wound
sites in PU.1/ mice were significantly decreased compared with
WT mice (Fig 2B), indicating that these four miRs are inflammation-
related miRNAs expressed during skin wound healing.
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Skin wound healing is delayed in miR-223Y/ mice
Of all inflammation-related miRNAs, miR-223 was the most highly
expressed during the inflammatory phase at wound sites and so the
present study focused on the molecular mechanisms of miR-223 in
skin wound healing (Appendix Fig S2). To determine which cells
expressed miR-223 during skin wound healing, we performed
immunohistochemistry (IHC) and in situ hybridization (ISH).
Wound-infiltrated neutrophils at day 1 in the wound site of WT mice
predominantly expressedmiR-223 (Fig 3A and B), and this was simi-
lar in human skin-inflamed sites (Fig 3C). We used qPCR to confirm
that murine wound-infiltrating neutrophils (1 day after wounding)
and macrophages (3 days after wounding) isolated by immunoaffin-
ity selection with anti-Ly-6G (neutrophil marker) and anti-CD11b
(macrophage marker) Abs (Tanaka et al, 2017) expressed miR-223
at the wound sites (Fig 3D). Thus, miR-223 is predominantly
expressed in neutrophils and macrophages at skin wound sites.
To clarify the pathophysiological role of miR-223 in skin wound
healing, we made dorsal skin wounds in miR-223Y/ mice. Gross
examination showed that wound closure was significantly delayed in
miR-223Y/ mice compared with WT mice (Fig 3E and F). We inves-
tigated re-epithelialization using histological analysis and observed
that epithelial wound tongues in miR-223Y/ mice at day 3 after
injury were significantly shorter (188.3  24.11 lm, P = 0.0115)
than in WT mice (380.1  47.08 lm; Fig 3G and H) confirming that
miR-223Y/mice showed delayed wound re-epithelialization.
We investigated the area of granulation tissue at day 7 and day
14 at wound sites in miR-223Y/ mice and found them to be
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Figure 1. Identification and expression of nine candidate inflammation-related miRNAs in skin wound healing.
Temporal expression of murinemiR-147,miR-223,miR-129-3p,miR-139-5p,miR-21*,miR-340-5p,miR-142-3p,miR-142-5p, andmiR-486 in skin wound healing measured by
qPCR relative to snoRNA202 or 5S rRNA (n = 4–6). All values represent the mean  SD. Tukey’s multiple comparison tests were used to generate the P-values indicated in the
Figure. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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significantly increased (day 7; 0.60  0.16 mm2, day 14;
0.18  0.064 mm2) compared with WT mice (day 7;
0.36  0.16 mm2, day 14; 0.11  0.036 mm2; Fig EV1A–C). We
examined the localization and expression level of a-smooth muscle
actin (aSMA), a marker of contractile myofibroblasts (Gabbiani
et al, 1971), using IHC. The expression of aSMA at day 7 in
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Figure 2. miR-139-5p, miR-142-3p, miR-142-5p, and miR-223 are independently expressed by wound inflammation.
A Temporal expression of miR-223, miR-142-3p, and miR-340-5p in skin wound healing of neonate mice using qPCR (n = 6).
B qPCR analysis indicates the expression levels of inflammation-related miRNAs at 3 h in wound sites of WT (n = 5), PU.1+/ (n = 6), and PU.1/ (n = 6) neonatal mice.
Data information: Results shown are the mean  SD. Tukey’s multiple comparison tests were used to generate the P-values indicated in the Figure. *P < 0.05,
**P < 0.01, ***P < 0.001, ****P < 0.0001.
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granulation tissues of miR-223Y/ mice was markedly decreased
(58%) compared with WT mice, even though the localization of
aSMA-expressing cells at day 7 in granulation tissues of miR-223Y/
mice was not altered when compared with WT mice (Fig EV1D and
E). Collectively, miR-223Y/ mice showed delayed skin wound heal-
ing and an increased scar area.
MiR-223 regulates neutrophils in the acute inflammatory
responses at wound sites
Because we found miR-223 was expressed in neutrophils at wound
sites and miR-223Y/ mice exhibited significantly delayed skin
repair, we investigated whether miR-223 regulates neutrophil func-
tions in acute inflammatory responses, in ways which might impact
on the recruitment of macrophages leading to a further chronic
inflammatory response. To investigate how miR-223 might regulate
the duration of the inflammatory response during skin wound heal-
ing in vivo, we examined neutrophil migration into wound sites
during repair using lysozyme M (lys)-enhanced green fluorescent
protein (lys-EGFP) mice, in which most myelomonocytic cells, espe-
cially mature neutrophil granulocytes, specifically express EGFP
(Faust et al, 2000). In vivo live imaging analysis using these mice
allowed semi-quantifiable evaluation of the spatiotemporal recruit-
ment of neutrophils to skin wound sites, because EGFP fluorescence
intensity is directly correlated with the number of neutrophils at
wound sites (Kim et al, 2008; Tanaka et al, 2017). At 3 h, neutro-
phils began to accumulate at the margins of wounds in WT:lys-EGFP
mice (by measuring EGFP fluorescence intensity) with the intensity
peaking at day 3 after injury (Fig 4A and B). In contrast, no migra-
tion or accumulation of neutrophils was observed in miR-223Y/:lys-
EGFP mice at 3 h after injury; however, after 12 h the number of
infiltrated neutrophils was greater than that of the WT neutrophil
influx. At day 3, the number of neutrophils measured by the inten-
sity of EGFP in miR-223Y/:lys-EGFP mice was significantly
increased compared with WT:lys-EGFP mice.
We next examined the function of neutrophils in vivo as an index
of myeloperoxidase (MPO) activation, a marker for neutrophil acti-
vation at wound sites (Mori et al, 2014). In vivo live imaging analy-
sis using luminescence was used to monitor dynamic changes in
neutrophil activation at skin wound sites. We found that MPO acti-
vation was markedly increased at wound sites of miR-223Y/ mice
compared with WT mice at day 1 and day 3 after injury, which
correlated with the amount of MPO at skin wound sites (Fig 4C–E).
2-[6-(40-amino)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (APF)
is a fluorescent probe that selectively binds to reactive oxygen
species (ROS) such as hydroxyl radicals, peroxynitrite, and
hypochlorite produced by MPO in neutrophils (Setsukinai et al,
2003). To dissect the time-dependent activation of neutrophils, we
performed live cell imaging analysis using confocal microscopy. We
observed that ROS production in peripheral blood neutrophils
(PBNs) derived from miR-223Y/ mice was markedly delayed after
incubation with phorbol myristate acetate (PMA) for 30 min (Fig 4F
and G; Movies EV1 and EV2). Interestingly, miR-223Y/ PBNs subse-
quently exhibited marked hyperactivation at 60 min compared with
◀ Figure 3. miR-223Y/ mice show delayed aseptic skin wound healing.A IHC of neutrophils (Ly-6G and Ly-6C) at day 1 wound sites. Arrowhead indicates the wound margin. Area indicated with a rectangle is shown at a higher
magnification below. Scale bars: 50 lm (bottom) and 500 lm (top).
B ISH of Mus musculus (mmu) miR-223 showing that wound-infiltrated neutrophils were predominantly present in the wound sites of adult WT mice at day 1 after
injury. Arrowhead indicates the wound margin. Area indicated with a rectangle is shown at a higher magnification below. Scale bars: 50 lm (bottom) and 500 lm
(top).
C Neutrophils express Homo sapiens (hsa) miR-223 in human skin-inflamed sites. Representative H&E staining (top) and ISH of miR-223 (bottom) showing that miR-
223-expressing neutrophils were predominantly present in patient skin-inflamed sites (n = 15, Appendix Table S3). Scale bars: 50 lm.
D qPCR analysis shows miR-223 was expressed by wound-infiltrating neutrophils (day 1) and macrophages (day 3) (n = 3).
E Representative photo images of the gross appearance of excisional wounds in WT (left) and miR-223Y/ (right) mice.
F Proportion of the wound area remaining open relative to initial wound area at each time point in WT (n = 14) and miR-223Y/ (n = 13) mice.
G H&E staining of re-epithelialization at day 3 after injury (wound margin (arrowheads) and the leading edge of epithelia (arrows)). Scale bar: 500 lm.
H Measurement of epithelial tongue at day 3 after injury in WT (n = 8) and miR-223Y/ (n = 5) mice.
Data information: All values represent the mean  SD. Two-way ANOVA followed by Sidak multiple comparisons test (F) and unpaired t-test (H) was used to generate P-
values indicated in the Figure. *P < 0.05, ***P < 0.001.
▸Figure 4. miR-223 regulates neutrophil activation at wound sites.A Representative in vivo fluorescent images of EGFP-expressing neutrophils at skin wound sites. Active fluorescent imaging on color scale overlaid on a gray scale image
of wounds sites.
B Recruitment of neutrophils at skin wound sites measured by in vivo fluorescence. All values indicate the mean radiant efficiency (photon/sec/cm2/sr)/(uW/cm2)
(n = 3).
C Representative in vivo MPO activity bioluminescence imaging on color scale overlaid on a gray scale image of wound sites.
D Measurements of MPO activity in vivo at wound sites of WT and miR-223Y/ mice. All values are the mean surface radians (photon/sec/cm2/sr) (day 1; n = 9, day 3;
n = 12).
E MPO concentrations measured by ELISA revealed MPO levels of miR-223Y/ mice were significantly increased compared with WT mice (intact skin; n = 4, day 1; n = 5
(miR-223Y/) or n = 8 (WT), day 3; n = 6 (miR-223Y/) or n = 5 (WT)).
F Representative live in vitro fluorescence imaging of ROS production in WT and miR-223Y/-derived neutrophils (Movies EV1 and EV2). Scale bar: 10 lm.
G Temporal ROS production in neutrophils from WT (32 neutrophils from 3 mice, blue) and miR-223Y/ (36 neutrophils from 3 mice, red) mice were measured at 60 min
after PMA stimulus.
Data information: Values represent the mean  SD (B, D, and E), or  SEM (G). Two-way ANOVA followed by Sidak multiple test (B), unpaired t-test (B, D, and E), and
Mann–Whitney U-test (G) were used to generate P-values indicated in the Figure. *P < 0.05.
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WT PBNs (14.6  2.4 in WT PBNs versus 26.1  4.3 in miR-223Y/
PBNs, P = 0.0113), suggesting miR-223 might be involved in neutro-
phil activation.
Macrophages infiltrate wound sites in the later inflammatory
phase after neutrophil migration (Eming et al, 2014). IHC for F4/80,
a macrophage marker (Austyn & Gordon, 1981), revealed that
macrophage numbers were significantly increased in the wound
sites of miR-223Y/ mice at day 3 and 7 after injury (Fig EV2A and
B). In agreement with the altered macrophage infiltration time
course, macrophage inflammatory protein (MIP)-1a was signifi-
cantly increased at day 3 after injury in the wound sites of miR-
223Y/ mice (Fig EV2C). Collectively, our in vivo and in vitro analy-
ses indicate that miR-223 might regulate the acute inflammatory
response at wound sites and subsequently affect macrophage infil-
tration into wound sites.
miR-223 regulates Il6 expression at wound sites
We investigated the molecular mechanisms of transcriptome regula-
tion by miR-223 at wound sites using NGS mRNA-Sequencing
(mRNA-Seq) of day 1 skin wound samples from miR-223Y/ and
WT mice (Dataset EV2). We screened potential miR-223 target
mRNAs using bioinformatics and our NGS data using a fold-change
cutoff of 1.5 (Appendix Fig S3). We identified 2 miR-223 target
mRNAs, Il6 (WT: 13.3, miR-223Y/: 31.3; 2.36-fold increase in
expression level) and Piccolo (Pclo), a presynaptic cytomatrix
protein (WT: 0.025, miR-223Y/: 0.043, 1.71-fold increase). Il6 is a
classic proinflammatory cytokine gene, and IL-6 protein is produced
locally at human skin wound sites 30 min after injury (Grellner
et al, 2000). IHC revealed that wound-infiltrating neutrophils
predominantly expressed and secreted IL-6 in WT and miR-223Y/
wound sites at day 1 (Fig 5A) and was significantly overexpressed
in miR-223Y/ wound sites at day 1 compared with WT mice
(Fig 5B). However, expression levels of IL-6 receptor-a (Il6ra), an
IL-6 signal transducer (Il6st) that is also a candidate miR-223 target
mRNA, and the proinflammatory cytokine gene Il1b were not
altered (Fig 5C–E). Interestingly, non-stimulated bone marrow-
derived miR-223Y/ neutrophils, but not WT neutrophils, constitu-
tively secreted IL-6 in vitro (Fig 5F). To determine whether miR-223
seed sequences dependently bind to Il6 target mRNAs in cells, we
designed three miR-223 point mutation mimics (Fig 5G). The miR-
223 mimic bound to the Il6 30-untranslated regions (UTRs) and was
seed sequence dependent compared with the control and two miR-
223 point mutation mimics with 2 and 4 point mutations in the seed
sequence, respectively (Fig 5H). These data suggest that miR-223
might directly regulate IL-6 translation and secretion from neutro-
phils at wound sites.
miR-223Y/ neutrophils contribute to improved healing of
Staphylococcus aureus-infected wounds
Staphylococcus aureus is the most common cause of skin infection
in humans and is frequently detected in severe chronic skin wound
sites in the clinic (Salgado-Pabon & Schlievert, 2014). Long-term
S. aureus infection can lead to methicillin-resistant S. aureus. Our
studies showed that miR-223Y/ neutrophils were hyperactivated
and because they expressed IL-6, which was important for S. aureus
clearance in a subcutaneous infection model using Il6/ mice
(Hruz et al, 2009), we investigated whether miR-223Y/ neutrophils
preferentially kill bacteria at wound sites. Wounds in WT and miR-
223Y/ mice were inoculated with S. aureus (1 × 108 colony-
forming units [CFU]/10 ll), which led to impaired wound healing
in WT mice; these wounds were still not healed by day 7 after
injury, with overt healing only initiated at day 10 to day 14. By
contrast, miR-223Y/ mice showed significantly enhanced healing of
S. aureus-infected wounds at day 3 and 7 compared with controls
(Fig 6A and B), accompanied by enhanced re-epithelialization,
reduced total wound area and pathological postinfectious necrotic
lesions without significant alteration in area of granulation tissue,
and the expression of aSMA in granulation tissues at day 7, but not
at day 14 (Fig EV3). However, the percentage of granulation tissue
area within the total wound area of miR-223Y/ mice at day 7 was
significantly increased (72.2%  23.1%, P = 0.0494) compared
with WT mice (35.4%  33.1). The colonization of S. aureus at day
3 in the wound sites of miR-223Y/ mice was significantly reduced
(3.67×104  7149 CFU/wound) compared with WT mice
(1.16 × 105  32,849 CFU/wound; Fig 6C).
Abscess formation is a defensive reaction of tissues to prevent
the spread of infecting bacteria to other sites and previous studies
showed it was indispensable for promoting healing in S. aureus-
infected wounds (Kobayashi et al, 2015). Our histological observa-
tions demonstrated a significantly increased abscess size in day 1
wounds in miR-223Y/ mice (0.25  0.04 mm2) compared with WT
mice (0.13  0.04 mm2; Fig 6D and E).
We also investigated the expression levels of neutrophil-derived
Il6 and Il1b that are positively linked to S. aureus clearance (Hruz
et al, 2009; Cho et al, 2012) by qPCR, and found that they were
both markedly increased in S. aureus-infected wound sites of miR-
223Y/ mice at day 3 compared with equivalent wound sites of WT
mice (Fig 6F).
▸Figure 5. Neutrophil IL-6 secretion is regulated by miR-223 at wound sites.A IHC for IL-6 (red) and neutrophils (green) shows neutrophils express IL-6 at day 1 after injury in WT and miR-223Y/ mice. Nuclei were counterstained with DAPI.
Secreted IL-6 was deposited around neutrophils and in wound sites. Scale bar: 10 lm.
B–E qPCR analysis indicates the expression levels of Il6 (B), Il6ra (C), Il6st (D), and Il1b (E) at day 1 in wound sites of WT and miR-223Y/ mice (n = 6).
F ELISA reveals non-stimulated bone marrow-derived miR-223Y/ neutrophils constitutively secreted IL-6 (n = 3). Non-stimulated bone marrow-derived WT
neutrophils were not detected.
G Alignment of seven miR-223 seed sequences and the corresponding seed sequences in Il6 mRNAs (red color and capital letters, respectively). Point mutations in
each mutation mimic are shown as green, brown, and blue, respectively. The digit indicates the 30-UTR position.
H miR-223 binds to Il6 30-UTRs with high affinity. A luciferase reporter vector encoding 30-UTRs was co-transfected with miR-223 mimics into 3T3 cells. A decrease in
luciferase activity indicates binding of the miR-223 mimic to the 30-UTR of the target sequence (n = 6–8).
Data information: All values represent the mean  SD. Unpaired Student’s t-test (B) and ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test
(miR-223 mimic vs each sample) (H) were used to generate P-values indicated in the Figure. *P < 0.05, **P < 0.01.
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Our studies described above suggest the potential beneficial
effects of cell transplantation therapy using miR-223Y/ neutrophils
engrafted in S. aureus-infected wound sites. To test the feasibility of
such a therapy, we applied bone marrow-derived neutrophils
(1 × 106 neutrophils in 50 ll of saline/wound, number of neutro-
phils was 1:100) to S. aureus-infected WT skin wound sites. We
confirmed that transplanted WT neutrophils remained in S. aureus-
infected skin wound sites up to 3 days after transplantation
(Appendix Fig S4A). miR-223Y/ neutrophil-treated skin wound sites
showed significantly improved healing accompanied by a reduced
total wound area and increased the expression of aSMA in granula-
tion tissues at day 7 and a reduced area of granulation tissue at 7
and 14 days when compared with non-treated or WT neutrophil-
treated S. aureus-infected wound sites (Fig 6G and H; Appendix Fig
S4B–E). This indicated that miR-223Y/ neutrophils might have ther-
apeutic benefit for S. aureus-infected skin wound healing.
Acute knockdown of miR-223 using AS ODNs at Staphylococcus
aureus-infected wounds sites improves healing
Our data provide experimental evidence that blocking miR-223
activity may improve S. aureus-infected skin wound healing.
Because molecular targeting by the delivery of AS ODN to wounds
knocked down specific mRNAs at skin wound sites (Mori et al,
2006, 2008, 2014), we wondered whether a similar approach might
knockdown miR-223 expression. To test this hypothesis and investi-
gate whether the acute knockdown of miR-223 activity might be a
feasible therapeutic strategy for improving the healing of infected
wounds, we designed and optimized locked nucleic acid (LNA)-
modified miR-223-specific AS ODN in vitro (Fig 7A and B).
We prepared a novel poloxamer P407/P188 binary thermosensi-
tive hydrogel (PB gel) that is highly effective for ODN delivery to
tissues. The characteristics of PB gel include its liquid form at room
temperature but rapid solidification at body temperature, efficient
release of 18-mer ODNs by 1 h (R. Takahashi et al, to be submitted
elsewhere), and 30% increased efficiency compared with poloxamer
Pluronic gel, which is currently a standard tool for ODN delivery to
wound sites (Mori et al, 2006, 2008, 2014; Fig EV4A and B). We
confirmed that the expression of miR-223 in control ODN (with a
sequence predicted to be non-binding to other mRNAs and
miRNAs)-treated S. aureus-infected skin wound sites was not
altered compared with control PB gel-treated S. aureus-infected skin
wound sites (Fig 7C). We applied miR-223-specific AS ODN in PB
gel versus control ODN in PB gel to S. aureus-infected skin wound
sites and confirmed that the expression of miR-223 in miR-223 AS
ODN-treated S. aureus-infected skin wound sites was significantly
decreased (6 h, 0.022  0.013; day 1, 1.16  0.45) compared with
control ODN-treated S. aureus-infected skin wound sites (6 h,
3.46  1.10; day 1, 7.57  1.12; Fig 7C and D). The expression of
IL-6 at day 1 in miR-223 AS ODN-treated S. aureus-infected skin
◀ Figure 6. miR-223Y/ neutrophils improve Staphylococcus aureus-infected skin wound healing.A Representative photo images of the gross appearance of S. aureus-infected wounds in WT (left) and miR-223Y/ (right) mice.
B Proportion of the wound area remaining open relative to initial wound area at each time point in S. aureus-infected WT (n = 11, blue) and miR-223Y/ (n = 13, red)
mice.
C Amount of S. aureus in wound sites of miR-223Y/ at day 3 were significantly decreased (n = 6).
D Representative images of H&E staining of abscess formation at day 1 wound sites. Arrowheads indicate wound margin. Scale bars: 500 lm.
E Measurement of abscess area of 1 day infected wounds (WT; n = 11, miR-223Y/; n = 12).
F qPCR analysis showed Il6, Il6ra, and Il1b expressions in S. aureus-infected wound sites of miR-223Y/ mice were significantly increased (WT; n = 16, miR-223Y/;
n = 15).
G Representative photo images of the gross appearance of non-transplant WT control (left), WT neutrophil-transplanted (middle), and miR-223Y/ neutrophil-
transplanted (right) wounds.
H Proportion of the wound area remaining open relative to initial wound area at each time point. Note that wound closure of miR-223Y/ neutrophil-transplanted sites
was significantly faster than non-transplant and WT neutrophil-transplanted wounds (WT control n = 11, WT neutrophil n = 12, miR-223Y/ neutrophil n = 13).
Data information: All values represent the mean  SD. Unpaired t-tests (E and F (Il6 and Il6ra)) followed by Welch’s test (C and F (Il1b)) and two-way ANOVA followed by
Sidak multiple test (B) and Tukey’s multiple test (H) were used to generate the P-values indicated in the Figure. *P < 0.05, **P < 0.01.
▸Figure 7. miR-223 AS ODN improves Staphylococcus aureus-infected skin wound healing.A L, and ^ indicate LNA, and phosphorothioated ODN, respectively. Alignment of miR-223 AS ODN sequences and the corresponding sequences in mature miR-223.
B Confirmation of miR-223 AS ODN binding activity in vitro. miR-223 AS ODN binds to the mature miR-223 region with a high affinity. A luciferase reporter vector
encoding the mature miR-223 was co-transfected with miR-223 AS ODN into 3T3 cells. A decrease in luciferase activity indicates binding of the control ODN to the
target sequence (n = 4).
C Expression of miR-223 in PB gel or control ODN-treated S. aureus-infected wound sites using qPCR (n = 4).
D Temporary expression of miR-223 in control ODN or miR-223 AS ODN-treated S. aureus-infected wound sites using qPCR (n = 4).
E Expression of Il6 at day 1 in control ODN or miR-223 AS ODN-treated S. aureus-infected wound sites using qPCR (n = 4).
F Representative photo images of the gross appearances of control and miR-223 AS ODN-treated wounds at various time points after wounding (n = 7).
G The proportion of the wound area remaining open relative to the initial S. aureus-infected wound area at each time point after the injury in control ODN versus miR-
223 AS ODN-treated wounds (n = 7).
H Measurement of total wound area, necrotic lesion area, and granulation tissue area at day 7 after injury in control ODN or miR-223 AS ODN-treated S. aureus-
infected wound sites (n = 6).
I Quantification of the expression of aSMA at day 7 in control ODN (n = 5) or miR-223 AS ODN-treated S. aureus-infected wound sites (n = 6).
J Measurement of the area of granulation tissues at day 14 in control ODN or miR-223 AS ODN-treated S. aureus-infected wound sites (n = 6)
Data information: All values represent the mean  SD. Unpaired t-tests (B, D, E, I, and J) followed by Welch’s correction (H) and two-way ANOVA followed by Sidak
multiple test (G) were used to generate the P-values indicated in the Figure. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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wound sites was significantly increased compared with control
ODN-treated S. aureus-infected skin wound sites (Fig 7E). Macro-
scopic analysis of wounds at day 3 and day 7 after injury indicated
that wound closure in miR-223 AS ODN-treated S. aureus-wound
sites was markedly accelerated (day 3; 73  19%, day 7;
41  30%) compared with control ODN-treated S. aureus-infected
wounds (day 3; 115  33%, day 7; 73  24%; Fig 7F and G).
Histological analysis indicated that the total wound area and
necrotic lesions in miR-223 AS ODN-treated S. aureus-infected
wound sites at day 7 were markedly decreased compared with
controls and were accompanied by the enhanced expression of
aSMA in granulation tissues (Fig 7H and I). The percentage of gran-
ulation tissue contribution to total wound area of miR-223 AS ODN-
treated S. aureus-infected wound sites was significantly increased
(80.9  17.7%, P = 0.0017) compared with control ODN-treated
S. aureus-infected wound sites (36.4%  18.6). By 14 days post-
wounding, the area of granulation tissue in miR-223 AS ODN-treated
S. aureus-infected wound sites was significantly reduced compared
with controls (Fig 7J). Our data suggest that the acute downregula-
tion of miR-223 at wound sites using miR-223 AS ODN accelerated
skin healing in S. aureus-infected wounds as effectively as miR-223-
deficient neutrophil transplantation, as described earlier.
IL-6 secretion from Staphylococcus aureus-recognizing human
neutrophils is regulated by C/EBPa-mediated miR-223 expression
To clarify the molecular mechanisms of the miR-223/IL-6 secretion
pathway in human neutrophils after infection with S. aureus, we
established a miR-223 knockdown human promyelocytic leukemia
HL-60 cell line that could be differentiated to neutrophils upon treat-
ment with DMSO usingmiR-223 AS ODN. As expected, the expression
of miR-223 in DMSO-treated HL-60 cells increased as they progressed
in their differentiation to mature neutrophils (Fig 8A) because miR-
223 contributed to neutrophil development (Johnnidis et al, 2008).
Next, we stimulated the differentiation HL-60 (dHL-60) cells with
S. aureus-derived peptidoglycan (PGN), a ligand for Toll-like recep-
tor (TLR)-2 (Takeuchi et al, 1999), and investigated the expression
pattern of miR-223 in neutrophils after the recognition of S. aureus.
The expression of miR-223 in dHL-60 cells stimulated with PGN at
6 h was significantly deceased (38%) compared with non-stimu-
lated dHL-60, to a similar degree when treated with miR-223 AS
ODN, indicating miR-223 expression is affected by PGN even though
miR-223 was knocked down by miR-223 AS ODN (Fig 8B and C).
Furthermore, even when miR-223 expression is strongly suppressed
by miR-223 AS ODN, if PGN stimulation (S. aureus recognition) is
received, positive feedback occurs; thus, through increased IL-6
production, infection control becomes more effective.
Il6 mRNA expression was markedly increased in non-PGN (4.9-
fold increase) and PGN-stimulated (2.7-fold increase) miR-223 AS
ODN-treated dHL-60 cells compared with controls (Fig 8D). The
concentration of IL-6 protein was significantly increased in condi-
tioned media from miR-223 AS ODN-treated dHL-60 cells compared
with controls at each time point and this corresponded to Il6 mRNA
levels (Fig 8E).
Finally, to investigate how miR-223 expression is regulated in
human neutrophils infected with S. aureus, we investigated expres-
sion of transcription factors C/EBPa (Fazi et al, 2005; Fukao et al,
2007), RUNX1 (Fazi et al, 2007), and PU.1 (Fukao et al, 2007) that
regulate miR-223 expression using qPCR. The expression of CEBPA,
but not RUNX1 and PU.1, in dHL-60 was significantly decreased
after 6-h stimulation with PGN compared with non-stimulated dHL-
60 cells (Fig EV5A). Finally, we confirmed the physical interaction
between C/EBPa and the miR-223 promotor locus in dHL-60 cells
after PGN stimulation because of the decreased levels of C/EBPa-
miR-223 promotor locus interaction compared with non-stimulated
dHL-60 cells using a chromatin immunoprecipitation (ChIP)-qPCR
assay (Fig 8F and G; Fig EV5B and C).
Non-activated, mature neutrophils, such as those in the circula-
tion, highly express miR-223 (Fig 8H), which is induced by C/EBPa
and leads to the inhibition of Il6 translation. By contrast, activated
neutrophils exposed to S. aureus downregulate miR-223 expression
concomitant with decreased C/EBPa and the subsequent induction
of Il6 translation.
Discussion
In the present study, we established novel Ago2-miRNAs purifica-
tion methods using NGS from skin wound tissues and identified skin
wound-induced miRNAs that might bind to target key wound
mRNAs. We identified four miRNA candidates that appear to be
wound inflammation-related by comparison of WT with PU.1/
mouse wounds. Of these, we demonstrated that miR-223Y/ mice
exhibited delayed sterile skin wound healing but that in S. aureus-
infected wounds, the addition of miR-223Y/ neutrophils, or knock-
down of miR-223 with AS ODNs significantly improved healing. The
▸Figure 8. Human neutrophil IL-6 secretion is regulated by the C/EBPa-miR-223 signaling pathway stimulated with Staphylococcus aureus PGN.A qPCR analysis was used to determine the expression levels of miR-223 in dHL-60 (n = 3).
B miR-223 AS ODN decreased miR-223 expression in dHL60 (control; n = 5, control ODN and miR-223 AS ODN; n = 6).
C Downregulation of miR-223 expression in dHL60 cells at 6 h after stimulation with PGN (n = 6).
D qPCR analysis indicates the expression levels of Il6 relative to beta-2-microglobulin (B2m) in non-stimulated and PGN-stimulated (6 h) dHL60 cells were markedly
increased compared with controls (n = 3) after miR-223 knockdown.
E ELISA revealed non-stimulated and PGN-stimulated dHL60 cells constitutively secreted IL-6 (n = 3–6).
F Decreased C/EBPa binding activity to the miR-223 promotor after PGN stimulation (PGN) in dHL-60 cells compared with non-stimulated dHL-60 cells (C, control)
revealed by ChIP assay. Full scans for electropherogram in Fig EV5C.
G Quantification of anti-C/EBPa Ab-ChIP relative to non-stimulated dHL-60 cells using ChIP-qPCR (n = 3).
H A model summarizing the interplay between S. aureus, C/EBPa, miR-223, and IL-6 secretion in neutrophils at wound sites.
Data information: All values represent the mean  SD. Ordinary one-way ANOVA followed by Holm-Sidak multiple comparisons test was used to generate P-values (day
0 versus each day) (A). Unpaired t-tests (C–E, and G) followed by Welch’s correction (B) were used to generate the P-values indicated. *P < 0.05, **P < 0.01,
****P < 0.0001.
Source data are available online for this figure.
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miR-223/Il6 pathway is regulated by C/EBPa and might have a criti-
cal role in S. aureus clearance. The present data provide a novel
molecular insight into the function of miR-223 in skin wound heal-
ing and suggest the potential therapeutic targeting of this miR in
conditions such as infected skin ulcers.
Previously, over 30 inflammation and immune response-related
miRNAs have been identified including miR-142-3p, miR-142-5p,
and miR-223 and our wound studies support a role for these
miRNAs in aspects of the wound inflammatory response (O’Connell
et al, 2012; Marques-Rocha et al, 2015). Recently, miR-139-5p/
mice were shown to develop colitis-associated tumorigenesis (Mao
et al, 2015) and thus represent a potential clinical biomarker for
cancer (Zhang et al, 2015). Our findings suggest that miR-139-5p is
also associated with inflammatory responses and tissue repair.
Previous reports have shown that miR-142 family members and
miR-223 may play critical roles in in vivo immune homeostasis.
miR-223 regulates granulocyte development and function (Johnnidis
et al, 2008), and using miR-142/ mice, several groups revealed
that miR-142 regulates the hematopoietic development and function
of mast cells, megakaryocytes, and lymphocytes (Mildner et al,
2013; Chapnik et al, 2014; Yamada et al, 2014; Sun et al, 2015). We
further investigated the function of miR-142 in skin wound healing
by analyzing a newly-developed miR-142 knockout mouse and
showed that this miR regulates neutrophil migration at skin wound
sites via the small GTPase regulation of its actin cytoskeleton
(Tanaka et al, 2017).
In the current study, we identified a role for miR-223 in the
inflammatory phase of murine skin wound healing. Furthermore,
we report the miR-223 seed sequence is critical for the regulation of
IL-6 expression and secretion. Recent studies have indicated roles
for miR-223 in numerous inflammation-related diseases, such as
tuberculosis, inflammatory bowel disease, diabetes, and cancers
(Chuang et al, 2015; Liu et al, 2015). Human and mouse studies by
Fukao et al (2007) suggest miR-223 might fine-tune the expression
of numerous genes during inflammatory episodes. A recent study
reported that miR-223 does not bind to Il6 mutation sites, suggesting
miR-223 directly targets Il6 in myeloid cells (Dorhoi et al, 2013).
Over twenty miR-223 targets associated with immunity have been
validated in humans and mice (Haneklaus et al, 2013). In addition,
the downregulation of miR-223 promoted Il6 and Il1b transcription
in a RAW264.7 macrophage cell line (Chen et al, 2012). Thus, miR-
223 might participate in trafficking pathways including the synthe-
sis, storage, and secretion of bioactive substances and de novo
synthesis of proinflammatory cytokines through transcriptional
regulation (Sheshachalam et al, 2014).
It was reported that IL6/ mice exhibited delayed aseptic skin
wound healing (Gallucci et al, 2000; Lin et al, 2003) and recombi-
nant murine IL-6 improved skin wound healing in glucocorticoid-
treated mice (Gallucci et al, 2001). In contrast, excess IL-6 causes
inflammatory diseases; therefore, IL-6 receptor antibody (Tocili-
zumab) has been used as therapeutic agent against Castleman
disease and rheumatic diseases in the clinic (Rubbert-Roth et al,
2018; Yoshizaki et al, 2018). Taken together, it appears that precise
regulation of IL-6 levels is necessary at inflamed sites to regulate
inflammation and tissue repair.
It is well established that neutrophils kill microbes through
various strategies including the release of ROS generated by
NADPH-dependent oxidase (Ellson et al, 2006). Previous studies
reported that miR-223Y/ neutrophils exhibited increased H2O2
production and were efficient at Candida albicans killing in vitro
(Johnnidis et al, 2008). miR-223 expression was markedly
increased in the inflamed pelvic sites of individuals suffering from
chlamydial genital infection (Yeruva et al, 2014), indicating miR-
223-expressing cells might be involved in many infectious diseases.
We wondered whether miR-223-expressing cells might play a role
in S. aureus-infected wounds. Indeed, we found that S. aureus-
infected miR-223Y/ murine wounds healed faster than in WT mice
during the early inflammation phase. Moreover, Il6 and Il1b
expressions, which contribute to S. aureus clearance in skin
wound sites (Hruz et al, 2009; Cho et al, 2012) and in keratitis
(Hume et al, 2006), were significantly higher in miR-223Y/
wounds. We mirrored the efficacy of cell transplantation therapy
against S. aureus-infected skin wounds using purified miR-223Y/
neutrophils, by delivery of miR-223 AS ODN knockdown of the
same miRNA which similarly resulted in a better and faster heal-
ing of infected wounds in mice and has more immediate therapeu-
tic applicability. Re-epithelialization and granulation tissue
formation at the aseptic wound sites of miR-223Y/ mice were
markedly delayed in contrast to the S. aureus-infected skin wound
sites of miR-223Y/, miR-223Y/ neutrophil-transplanted, and miR-
223 AS ODN-treated groups, which were significantly improved
compared with each control. This is likely a consequence of
increased acute inflammatory responses (secondary effect),
because miR-223 was not expressed in wound-infiltrated fibro-
blasts or keratinocytes.
In this study, we found that activating human neutrophils by
exposure to S. aureus peptide downregulated miR-223 associated
with the attenuation of C/EBPa that is required for S. aureus clear-
ance in vivo. It has previously been reported that murine neutro-
phils produced IL-6 after PGN stimulation (Strassheim et al, 2005).
C/EBPa expression was downregulated by PGN and lipopolysaccha-
ride in microglial cells, whereas Il6 and Il1b did not affect C/EBPa
expression (Ejarque-Ortiz et al, 2007). Indeed, the TLRs-C/EBPa-
miR-223 signaling pathway is likely to be the predominant early
phase signaling pathway driving bacteria clearance, rather than
cytokine signaling.
Because we showed that miR-223 is also upregulated in human
inflamed tissues, it is tempting to speculate that these therapeutic
approaches may also translate to human chronic wounds. Chronic
wounds affect 6.5 million patients annually, and 25 billion USD is
spent in the United States to combat this (Sen et al, 2009). Infected
chronic wounds frequently show a poor response to treatment and
are difficult to cure; therefore, there is an enormous economic and
social impact worldwide. We hope that a deeper understanding of
miR-223 molecular mechanisms may aid the development of novel
drugs and cell-based therapies to enhance the healing of chronically
infected wounds.
Materials and Methods
Mice and wound model
All experiments were conducted according to the provisions of the
Ethics Review Committee for Animal Experimentation at Nagasaki
University. Mice were maintained in a barrier facility (temperature;
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22–25°C, 12-h light/dark cycle) under specific pathogen-free condi-
tions. Mice were fed ad libitum with Charles River-LPF diet
(360 kcal/100 g; 13% fat calories, 26% protein calories, and 61%
carbohydrate calories [Oriental Yeast, Tokyo, Japan]). miR-223Y/
mice were generated as described previously (Johnnidis et al,
2008). The miR-223 locus is located on the X chromosome and is
transcribed independently of any known genes, so that miR-223Y/
hemizygous male mice are completely deficient in mature miR-223
expression. WT male mice (6–12 weeks) and miR-223Y/ male mice
(B6.Cg-Ptprca Mir223tm1Fcam/J, 6–12 weeks [The Jackson Labora-
tory, Bar Harbor, ME, USA]) were anaesthetized and 2 or 4 full-
thickness excisional wounds (4-mm biopsy punch; Kai Industries,
Gifu, Japan) were aseptically made to the shaved dorsal skin. Gener-
ation of PU.1/ mice was described previously (McKercher et al,
1996). One-day-old pups received anesthetic and full-thickness 1-cm
incisional wounds were performed on the dorsal skin; then, the
wounds were harvested.
Faust et al (2000) generated lys-EGFP mice as described previ-
ously. To generate male lys-EGFP-expressing miR-223Y/ mice, male
miR-223Y/ mice were crossed with female lys-EGFP mice to
produce lys-EGFP heterozygous-expressing male miR-223Y/ and
female miR-223+/ mice. A second cross generated male lys-EGFP
homozygous-expressing miR-223Y/ mice. Mice genotypes were
defined by PCR as previously described (Faust et al, 2000; Johnnidis
et al, 2008).
Staphylococcus aureus type strain (NBRC 100910) was obtained
from the National Institute of Technology and Evaluation (Tokyo,
Japan). In the S. aureus-infected group, mice were locally inocu-
lated with S. aureus (1 × 108 CFU per 10 ll in saline) at pre-skin
wound sites followed by making the wound.
For wound area analysis, digital images of wound areas were
measured by Photoshop CC (Adobe Systems, San Jose, CA, USA)
and the mean wound area was calculated from two or four wounds
from a single mouse (Mori et al, 2008, 2014; Tanaka et al, 2017).
Extraction and purification for miRNA from skin wounds
Wounds in mice were harvested with a 6-mm biopsy punch, and
miRNAs were extracted/purified using the microRNA Isolation Kit,
Mouse Ago2 (Wako Pure Chemical Industries Ltd, Osaka, Japan)
according to the manufacturer’s instructions. Briefly, 4 wound
tissues were placed in cell lysis buffer and homogenized for 5 min,
incubated on ice for 15 min, and centrifuged at 14,000 g for 15 min
at 4°C. Debris in supernatants was eliminated using an Ultrafree-MC
0.45-lm filter (Merck Millipore, Darmstadt, Germany). Filtrated
supernatants were immunoprecipitated with anti-mouse Ago2 Ab
for 3 h at 4°C. Samples were washed with cell lysis buffer 3 times,
and miRNAs were eluted by elusion solution. miRNAs were purified
and precipitated by standard phenol/chloroform extraction and
ethanol precipitation methods.
MiRNA library construction and high-throughput
whole-miRNAs sequencing
Cloning of miRNAs was performed using a small RNA Cloning Kit
(Takara Bio, Shiga, Japan) according to the manufacturer’s instruc-
tions (Appendix Fig S1). Briefly, purified-miRNAs were treated with
Bacterial Alkaline Phosphatase to dephosphorylate the 30 end of
miRNAs at 37°C for 1 h, then purified and precipitated by standard
phenol/chloroform extraction and ethanol precipitation methods.
Dephosphorylated-30 ends of miRNAs were bound to biotinylated-30
adaptors using T4 RNA ligase at 15°C for 1 h, reacted with
MAGNOTEX-SA (Takara Bio), a streptavidin conjugated-magnetic
bead and then washed. Magnet bead-conjugated miRNAs were
phosphorylated at the miRNA 50 end using T4 polynucleotide kinase
at 37°C for 30 min, bound with 50 adaptors using T4 RNA ligase at
15°C for 1 h, and then washed. Finally, miRNAs were transcribed to
cDNA and amplified using ExTaq Hot Start Version (Takara Bio).
Specific primers were as follows: (Forward) 50-AAAGATCCTG
CAGGTGCGTCA-30 and (Reverse) 50-GTCTCTAGCCTGCAGGATC
GATG-30. Amplification was performed for 15 cycles with annealing
at 60°C for 30 s, extension at 72°C for 30 s, and a final extension for
3 min. First PCR products were amplified with the same conditions
as for the 1st PCR methods. Second PCR products (approximately
65 bp) were separated by electrophoresis on a 10% TBE gel stained
with SYBR Gold nucleic acid gel stain (Invitrogen, Carlsbad, CA,
USA). Second PCR products were extracted from the gel and purified
using a small RNA gel Extraction kit (Takara Bio) according to the
manufacturer’s instructions. Purified 2nd PCR products were ampli-
fied using ExTaq Hot Start Version (Takara Bio) with the same
conditions as for the 1st PCR methods. Specific primers were as
follows: (Forward) 50-AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCTAAAGATCCTGCAGGTGC
GTCA-30 and (Reverse) 50-CAAGCAGAAGACGGCATACGAGCTCTT
CCGATCTGTCTCTAGCCTGCAGGATCGATG-30.
Third PCR products (approximately 156 bp) were separated by
electrophoresis on a 10% TBE gel stained with SYBR Gold nucleic
acid gel stain (Invitrogen). Target PCR products were extracted from
gels and purified using a small RNA gel Extraction kit (Takara Bio)
according to the manufacturer’s instructions. Purified miRNA
libraries were subjected to Solexa sequencing system (Illumina, San
Diego, CA, USA) according to the manufacturer’s instructions.
miRNA-Seq data reported are available in the DNA Data Bank of
Japan (DDBJ, http://trace.ddbj.nig.ac.jp/DRASearch/) under acces-
sion no. DRA004094.
Analysis of miRNA sequencing data
All individual sequence reads with base quality scores were
trimmed and eliminated from ineffective sequencing in the initial
data. Resulting sets of unique sequence reads were mapped onto the
mouse genome with reference to Langmead et al (2009) using the
UCSC Genome Bioinformatics Site. To identify sequence tags origi-
nating from known ncRNA (miRNA, other species miRNA, piRNA,
rRNA, tRNA, snRNA, snoRNA, scRNA, miscRNA) and transcripts,
we used miRBase (http://www.mirbase.org/index.shtml), NCBI
Entrez Nucleotide database (http://www.ncbi.nlm.nih.gov/sites/en
trez/query.fcgi?db=Nucleotide), and Reference Sequences (ftp://
ftp.ncbi.nih.gov/), as well as Ensembl Genome Browser (ftp://ftp.
ensembl.org/pub/release55/).
qPCR
Harvested tissues were homogenized by TissueLyzer II (Qiagen,
Hilden, Germany), and total miRNAs and mRNAs were extracted/
purified using an miRNeasy Mini Kit (Qiagen) and RNeasy Plus
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Universal Mini Kit (Qiagen), respectively, according to the manufac-
turers’ instructions. Quantification of miRNAs was performed by
TaqMan MicroRNA Assay (Applied Biosystems, Foster City, CA,
USA) and the miRCURY LNA microRNA PCR system (Exiqon,
Vedbaek, Denmark) using ABI PRISM 7900HT (Applied Biosys-
tems). Quantification of mRNAs was performed with Thunderbird
SYBR qPCR Mix (Toyobo Inc., Osaka, Japan) using ABI PRISM
7900HT (Applied Biosystems) (sequences of primers are shown in
Appendix Table S6).
Histology
Harvested tissues were fixed in 4% paraformaldehyde (PFA) over-
night and embedded in paraffin. All specimens were cut to 4-lm-
thick sections and subjected to hematoxylin and eosin (H&E), ISH,
and IHC (Ab information in Appendix Table S5). IHC and quan-
tification of macrophages and aSMA expression were performed as
previously described (Mori et al, 2006, 2008, 2014). Observations
were made via digital whole slide scanning system (Aperio AT
Turbo; Leica Microsystems, Tokyo, Japan) confocal microscopy
(C2+ system; Nikon Corp., Tokyo, Japan)]. Aperio eSlide Manager
(Leica Microsystems), NIS-Elements C software version 4.13 (Nikon
Corp.), AR software version 4.0 (Nikon Corp.), or IMARIS 7.7.2
(Bitplane, Zurich, Switzerland) were used for data analysis.
ISH
In situ hybridization was performed using microRNA ISH buffer set
and miRCURY LNA Detection 50- and 30-DIG-labeled probes (Exiqon)
according to the manufacturer’s instructions. In brief, 4% PFA perfu-
sion-fixed tissues were embedded in paraffin. Six-lm sections were
deparaffinized and incubated with Proteinase K solution (Dako,
Glostrup, Denmark) for 10 min at 37°C. After washing in PBS,
sections were dehydrated. Hybridization was performed using
40 nM of miRNA probe in microRNA ISH buffer (Exiqon) at 55°C for
2 h. Sections were rinsed in 5× SSC at 55°C for 5 min, twice with 1×
SSC at 55°C for 5 min, twice with 0.2× SSC at 55°C for 5 min, and
with 0.2× SSC at room temperature for 5 min. Sections were treated
with blocking solution (Nacalai Tesque Inc., Kyoto, Japan) for 1 h at
room temperature and then were incubated with anti-DIG Ab (1:800;
Roche Diagnostics GmbH, Mannheim, Germany) in blocking solu-
tion (Nacalai Tesque Inc.) overnight at 4°C. Sections were developed
using NTB/BCIP (Roche Diagnostics GmbH) at 30°C.
Isolation of neutrophils and macrophages from skin wounds and
bone marrow
Neutrophils and macrophages were isolated with a MicroBead Kit
(Miltenyi Biotech Inc., Bergisch Gladbach, Germany) according to
the manufacturer’s instructions. Cells were reacted with anti-Ly-6G
Ab and anti-CD11b Ab to isolate neutrophils and macrophages,
respectively (Tanaka et al, 2017).
In vivo live imaging analysis of EGFP-expressing neutrophil
recruitment and MPO activity at wound sites
Neutrophil recruitment at skin wound sites was visualized and
measured as previously described (Kim et al, 2008; Tanaka et al,
2017). In brief, WT:lys-EGFP mice and miR-223Y/:lys-EGFP mice
were wounded and fluorescence intensity was monitored with IVIS
Lumina II System (PerkinElmer, Waltham, MA, USA). Fluorescence
intensities were expressed as the mean radiant efficiency ((p/sec/
cm2/sr)/(uW/cm2).
To visualize and measure MPO activity in vivo, mice were
intraperitoneally injected with XenoLight RediJect Inflammation
Probe (5 ll/g body weight; PerkinElmer) on day 1 and 3 after
injury, and luminescence images were acquired at 10 min after
probe injection with the IVIS Lumina II System (PerkinElmer).
Luminescence intensities were expressed as the mean radiance
(photons/second/cm2/steradian). Living Image software (Perkin-
Elmer) was used to analyze the intensities of each wound.
Measurement of MPO, MIP-1a, and IL-6 protein concentrations
Extraction of total protein was performed as previously described
(Mori et al, 2014). Briefly, harvested tissues were homogenized by
TissueLyzer II (Qiagen) and T-PER Reagent (Thermo Fisher
Scientific, Waltham, MA, USA), consisting of proteinase and dephos-
phorylation inhibitor. Sample proteins were filtered using an
Ultrafree-MC 0.45-lm filter (Millipore). Concentrations of MPO and
MIP-1a were measured with an MPO mouse ELISA kit (Abcam,
Cambridge, UK) and a Bio-Plex Pro mouse cytokine G1 23-Plex panel
(Bio-Rad Laboratories, Inc. Hercules, CA, USA), respectively.
Murine neutrophils were isolated from bone marrow with a
MicroBead Kit (Miltenyi Biotech Inc.) according to the manufac-
turer’s instructions. Cells were cultured in RPMI 1640 at 37°C in 5%
CO2 for 5 h. Concentrations of mouse IL-6 in conditioned media
were measured by Mouse IL-6 Quantikine ELISA kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer’s instruc-
tions.
Live imaging analysis of neutrophil ROS production in vitro
Measurement of hypochlorite production was detected using APF
(Goryo Chemical Inc., Sapporo, Japan) according to the manufac-
turer’s instructions. In brief, 1 drop of tail vein peripheral blood was
added to 2 ml of live cell imaging solution (Gibco, Carlsbad, CA,
USA), and stained with 10 lM of APF for 30 min at room tempera-
ture. APF-loaded neutrophils were stimulated with 1 ll PMA, and
fluorescence images were acquired every 1 min for 60 min using a
confocal laser scanning unit microscope (C2+ system, Nikon Corp.)
equipped with Plan Apo VC20x (0.75 NA), and the images were
processed using IMARIS software (Bitplane).
RNA-Seq
Wound tissues harvested at day 1 were homogenized by Tissue-
Lyzer II (Qiagen) followed by total RNA and polyA+ RNA purifica-
tion using an RNeasy Plus Universal Mini Kit (Qiagen) and TruSeq
Stranded Total RNA Library Prep Kit (Illumina), respectively. mRNA
libraries were constructed with a TruSeq Stranded mRNA LT Sample
Prep Kit (Illumina) according to the manufacturer’s instructions
(TruSeq Stranded mRNA Sample Preparation Guide Rev.E). RNA-
Seq was performed with HiSeq 2500 (Illumina). RNA-Seq data
reported are available in the DNA Data Bank of Japan under acces-
sion no. DRA004092.
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Assay for miRNA binding to the 30-UTR of mRNA
The 30-UTRs of miR-223 targets were screened using Strand NGS
software (Strand Genomics, San Francisco, CA, USA). Vectors were
constructed with pmirGLO Dual-Luciferase miRNA Target Expres-
sion Vector (Promega Corp., Madison, WI, USA) according to the
manufacturer’s procedures and as previously described (Tanaka
et al, 2017). In brief, primers consisting of the 30-UTRs of predicted
miR-223 family target sequences and appropriate restriction sites
were synthesized, annealed, and cloned downstream of the firefly
luciferase reporter (luc2) gene in pmirGLO. Sequences were as
follows: Il6 sense (78–106) 50-aaacCTTATGTTGTTCTCTACGAAGAA
CTGACAt-30; and Il6 antisense (106–78) 50-ctagaTGTCAGTTCTTCG
TAGAGAACAACATAAGgttt-30. Capital and lowercase letters
indicate the 30-UTR and restriction sites (PmeI and XbaI),
respectively.
Double-strand miR-223 mimic and miR-223 point mutation
mimics were purchased from GeneDesign Inc. (Osaka, Japan).
Sequences were as follows (underline indicates a mutation point):
miR-223-3p 50-UGUCAGUUUGUCAAAUACCCCA-30; miR-223-3p
point mutation (No. 1) 50-UGCCAGUUUGUCAAAUACCCCA-30; miR-
223-3p point mutation (No. 2) 50-UGCGAGUUUGUCAAAUACCCCA-
30; and miR-223-3p point mutation (No. 3) 50-UGCGAGCCUGUC
AAAUACCCCA-30.
3T3 cells were co-transfected with a miR-223 mimic and reporter
vector using Lipofectamine 3000 (Life Technologies). Luciferase
activity was measured with a Dual-Glo Luciferase Assay System
(Promega Corp.) using the manufacturer’s procedure.
Neutrophil transplantation
Neutrophils were isolated from bone marrow using a Neutrophil
Isolation Kit (Miltenyi Biotech Inc.) according to the manufacturer’s
instructions. Isolated neutrophils (1 × 106 cells/50 ll in saline)
were locally applied at day 1 after inoculating S. aureus to wound
sites.
Generating miR-223 AS ODN
To obtain mature miR-223-expressing vector, vectors were
constructed with pmirGLO Dual-Luciferase miRNA Target Expres-
sion Vector (Promega Corp) according to the manufacturer’s proce-
dures. In brief, oligos consisting of the miR-223 sequences and
appropriate restriction sites were synthesized, annealed, and cloned
downstream of the luc2 gene in pmirGLO. Sequences were as
follows: miR-223 sense 50-aaacTGTCAGTTTGTCAAATACCCCAt-30;
and miR-223 antisense 50-ctagaTGGGGTATTTGACAAACTGACAgttt-
30. Capital and lowercase letters indicate the mature miR-223 and
restriction sites (PmeI and XbaI), respectively.
Control ODN and miR-223 AS ODN were originally designed and
had sequences as follows: Control ODN 50-G(L)^5(L)^A(L)^G(L)
^a^t^t^g^t^a^c^g^a^5(L)^T(L)^5(L)^A(L)^5(L)-30; and miR-223 AS
ODN 50-G(L)^G(L)^T(L)^A(L)^t^t^t^g^a^c^a^a^a^5(L)^T(L)^G(L)
^A(L)^5(L)-30.
L, ^, and 5(L) indicate LNA, phosphorothioated ODN, and LNA-
modified 5-methylcytosine, respectively (Fig 6A).
3T3 cells were co-transfected with control ODN or miR-223 AS
ODN and the reporter vector using Lipofectamine 3000 (Life
Technologies). Luciferase activity was measured with a Dual-Glo
Luciferase Assay System (Promega Corp.) using the manufacturer’s
procedure.
miR-223 knockdown at skin wound sites using miR-223 AS ODN
For in vivo experiments involving ODN delivery, ODNs [10 lM in
50 ll poloxamer P407/P188 (25%/4%; BASF, Ludwigshafen am
Rhein, Germany) binary thermosensitive hydrogel and 30%
Pluronic F-127 gel (Sigma-Aldrich, St. Louis, MO, USA), which acts
as a slow release vehicle (Mori et al, 2006, 2008, 2014)] were topi-
cally applied at 1 day after inoculation with S. aureus.
Human skin sample
Human skin samples were harvested from Japanese patients at the
time of surgery, and diagnosis was confirmed by routine pathologi-
cal examination (Appendix Table S4). All experiments were
conducted with the approval of the ethics committee of Nagasaki
University Graduate School of Biomedical Sciences, in accordance
with the WMA Declaration of Helsinki and the Department of Health
and Human Services Belmont Report.
Induction of neutrophilic differentiation and analysis for gene
expression stimulation with S. aureus PGN
The HL-60 cell line (RBRC-RCB0041) was provided by RIKEN
BRC through the National Bio-Resource Project of MEXT, Japan.
HL-60 cell culture and neutrophilic differentiation were previ-
ously described (Shuto et al, 2007). Neutrophilic differentiation
was induced by exposing HL-60 cells to 1.3% DMSO for 5 day.
At 3 day after exposure to 1.3% DMSO, HL-60 cells were trans-
fected with control or miR-223 AS ODN using Lipofectamine
3000 (Life Technologies) in Opti-MEM with 1.3% DMSO (Life
Technologies). On 2 day after transfection, cells and conditioned
media were harvested and applied to gene expression assays and
ELISA (Human IL-6 ELISA Kit, Sigma-Aldrich, St. Louis, MO,
USA).
ChIP-qPCR assay
ChIP-qPCR assay was performed with ChIP-IT PBMC (Active Motif,
Carlsbad, CA, USA) according to the manufacturer’s instructions.
Briefly, crosslinking of proteins to DNA was achieved by direct
treatment of 1% formaldehyde to non-stimulated or PGN-stimulated
dHL60 cells (1 × 107 cells) for 15 min at room temperature. Chro-
matin was sonicated with a Covaris M220 (Covaris Inc., Woburn,
MA, USA). Sonication conditions were as follows: duty factor 5%,
peak incident power 75, cycles per burst 200, water temperature
7°C, and duration 15 min. Sonicated chromatin was immunoprecipi-
tated for 16 h at 4°C with anti-C/EBPa Ab (GeneTex Inc., Irvine,
CA, USA), anti-Histone H3 Ab (Cell Signaling Technology Inc.,
Danvers, MA, USA), and anti-IgG isotype control Ab
(Appendix Table S5).
ChIP-PCR was performed with GoTaq Master Mix and Poly-
merase (Promega Corp., Madison, WI, USA) according to the manu-
facturer’s instructions. In brief, ChIP-DNA fragments (0.25 lg/
reaction) were amplified by PCR using the following primers that
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recognize the human C/EBPa binding miR-223 promotor site as
described (Fazi et al, 2005; Appendix Table S6): ChIP-PCR primer
(Forward) 50-GCCCTCTTTGTTGATGTGTC-30 and primer#1 (Rev-
erse) 50-GGCAGCTATTAAAGTGCCCT-30 for the 1,030/810 frag-
ment with respect to the end of the pre-miR-223 sequence (210 bp).
Annealing was performed at 55°C followed by 35 amplification
cycles. PCR products were separated by electrophoresis on 2%
agarose gels (Fig 8F; Fig EV5D). ChIP-qPCR was performed with
Thunderbird SYBR qPCR Mix (Toyobo Inc.) using an ABI PRISM
7900HT Sequence Detection System.
Statistical analysis
Data are shown as the means  SD or SEM (Fig 4G only). The
statistical significance of differences between means was assessed
by ANOVA, followed by Tukey’s test for multiple comparisons,
Dunnett’s multiple comparisons test, the Mann–Whitney U-test or
by an unpaired Student’s t-test followed by Welch’s test when only
two groups were analyzed. Multiple comparison tests were
performed using two-way ANOVA followed by Sidak multiple
comparisons test or by Holm-Sidak multiple comparisons test using
GraphPad Prism software (GraphPad Software, San Diego, CA,
USA) (Appendix Table S7).
Data availability
miRNA-Seq data reported are available in the DNA Data Bank
of Japan (DDBJ) under accession no. DRA004094 (http://ddbj.
nig.ac.jp/DRASearch/submission?acc=DRA004094). RNA-Seq data
reported are available in the DDBJ under accession no. DRA004092
(http://ddbj.nig.ac.jp/DRASearch/submission?acc=DRA004092).
Expanded View for this article is available online.
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